Please use this identifier to cite or link to this item:
Title: Immunohistochemistry in the era of personalised medicine
Authors: McCourt, C.M.
Boyle, D.
James, J.
Salto-Tellez, M. 
Issue Date: Jan-2013
Citation: McCourt, C.M., Boyle, D., James, J., Salto-Tellez, M. (2013-01). Immunohistochemistry in the era of personalised medicine. Journal of Clinical Pathology 66 (1) : 58-61. ScholarBank@NUS Repository.
Abstract: Background: Immunohistochemistry (IHC) plays a central role in the histopathological classification of diseases, including cancer. More recently, the importance of immunohistochemical staining is increasing. IHC usage in diagnostics is invaluable; however, the genetic and therapeutic significance of biomarker immunostaining has become equally relevant. Content: In this article, we would like to analyse the three distinct roles of IHC and review their individual impacts on modern diagnostic pathology: (1) diagnostic IHC; (2) genetic IHC and (3) therapeutic IHC. Summary: Thus, we will characterise the different analytical processes that are required in the three approaches to IHC usage stated above, as well as the clinical significance and overall importance in patient management. This will allow us to hypothesise on the most appropriate laboratory environment and detection methods for the future.
Source Title: Journal of Clinical Pathology
ISSN: 00219746
DOI: 10.1136/jclinpath-2012-201140
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Jan 19, 2023


checked on Jan 19, 2023

Page view(s)

checked on Jan 26, 2023

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.